Acute viral myocarditis: role of immunosuppression: a prospective randomised study

@article{Aziz2010AcuteVM,
  title={Acute viral myocarditis: role of immunosuppression: a prospective randomised study},
  author={Kalim Uddin Aziz and Najma Patel and Tareen Sadullah and Habiba Tasneem and Hasina Thawerani and Saeed Talpur},
  journal={Cardiology in the Young},
  year={2010},
  volume={20},
  pages={509 - 515}
}
Abstract Objective To conduct a prospective randomised study to show the efficacy of immune suppression with prednisolone, administered at the 3-month duration of acute myocarditis. Methods The diagnosis of acute viral myocarditis was made based on echocardiography and serum viral antibodies. The inclusion criterion was acute myocarditis of 3 months duration. In all, 68 of 173 children were available for randomisation into a prednisolone-treated group of 44 and a control group of 24 children… Expand
Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
TLDR
The present evidence does not support corticosteroids as superior to conventional therapy in children with myocarditis, and IVIG might be beneficial to improve LVEF and survival forMyocarditis in children. Expand
Efficacy of immunosuppressive therapy in myocarditis: A 30-year systematic review and meta analysis.
TLDR
A tailored IS may be considered in myocarditis, depending on the phase of the disease, and the type of underlying autoimmune or immune-mediated form. Expand
Immunosuppressive Treatment for Myocarditis in the Pediatric Population: A Meta-Analysis
TLDR
There may be a possible benefit, in the short term, to the addition of immunosuppressive therapy in the management of myocarditis in the pediatric population, however, further prospective investigation is warranted to validate this finding. Expand
Immunosuppressive treatment for myocarditis: a meta-analysis of randomized controlled trials
TLDR
Immunosuppressive treatment might be beneficial for improving left ventricular systolic function and remodeling in patients with myocarditis, which could be considered as a therapeutic alternative when optimal conventional therapy is not effective. Expand
In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy
TLDR
It was revealed that high-dose steroid or IVIG therapy had no significant effects on major in-hospital complications, late heart failure hospitalization, and long-term mortality. Expand
Corticosteroids for viral myocarditis.
TLDR
For people diagnosed with viral myocarditis and low LVEF, corticosteroids do not reduce mortality but they may improve cardiac function but the trials were of low quality and small size so this finding must be regarded as uncertain. Expand
Management of acute myocarditis in children.
TLDR
Myocarditis is a challenging diagnosis to make on clinical grounds and requires high index of suspicion, but the overall prognosis of the disease is good with survival rates up to 80%. Expand
Diverse stage-dependent effects of glucocorticoids in a murine model of viral myocarditis.
TLDR
Early administration of DEX is beneficial in the treatment of fulminant viral myocarditis, whereas late administration ofDEX is harmful, and it is speculated that a direct action of DeX on cardiomyocytes, rather than anti-inflammatory effects of DEx on immune cells, confers resistance to myocardial damage induced by viral infection. Expand
STUDENTS' CORNER REVIEW ARTICLE Management of acute myocarditis in children
TLDR
Myocarditis is a challenging diagnosis to make on clinical grounds and requires high index of suspicion, but the overall prognosis of the disease is good with survival rates up to 80%. Expand
Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
TLDR
The aim of this review is to approach the recently discovered facets of paediatric myocarditis regarding its progression to dilated cardiomyopathy. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 48 REFERENCES
Immunosuppressive therapy in acute myocarditis: an 18 year systematic review
TLDR
Current data suggest that immunosuppressive therapy does not significantly improve outcomes in children with acute myocarditis and there is insufficient evidence for its routine use. Expand
Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy
TLDR
The high long term survival rate of this cohort of children with myocarditis is probably due to the effect of short term immunosuppression, which differs from previously published series of conventionally treated children, whose survival probability at one year was about 60. Expand
Clinical outcome of acute myocarditis in children according to treatment modalities
TLDR
There was no difference between the IVIG-treated patients and the control patients in the degree of recovery of left ventricular function and survival one year after the initial presentation. Expand
Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial.
TLDR
Immunosuppressive therapy in this pediatric population appeared useful in improving the clinical course and cardiac function in acute myocarditis with no adverse side effects. Expand
Gamma-globulin treatment of acute myocarditis in the pediatric population.
TLDR
It is suggested that use of high-dose IVIG for treatment of acute myocarditis is associated with improved recovery of left ventricular function and with a tendency to better survival during the first year after presentation. Expand
Clinical outcomes of acute myocarditis in childhood
TLDR
Good outcomes in paediatric patients presenting with acute heart failure secondary to acute lymphocytic myocarditis treated with immunosuppression are recorded, with the absence of significant arrhythmias, continued cardiac medications, or restrictions in physical activity. Expand
Use of OKT3 for acute myocarditis in infants and children.
  • J. Ahdoot, A. Galindo, +5 authors H. Laks
  • Medicine
  • The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • 2000
TLDR
In patients with severe acute myocarditis, aggressive immunosuppressive regimen based on OKT3 is safe and may inhibit or reverse the immune response, resulting in dramatic improvement in myocardial function. Expand
Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence
TLDR
This study was set in an area where Chagas disease was endemic and the results are unlikely to apply to European and North American populations where entero-, adeno- and parvovirus infections predominate as causes of paediatric myocarditis. Expand
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy.
TLDR
It is concluded that endomyocardial biopsy can be used to diagnose inflammatory myocarditis and to monitor the histologic results of therapy, and circumstantial evidence that immunosuppressive therapy is effective in eliminating myocardial cell inflammation and thereby improvingMyocardial performance is found. Expand
Outcomes for children with acute myocarditis
TLDR
In patients with biopsy-proven myocarditis, treatment with intravenous immune globulin appeared to confer no advantage to steroid therapy alone, and the need for randomised trials to assess the efficacy of current treatments, as well as that of new therapies is emphasised. Expand
...
1
2
3
4
5
...